| P50 | author | Stephanie Erika Bonn | Q83490962 |
| | Marian L Neuhouser | Q88790119 |
| P2093 | author name string | Gary Goodman | |
| | Mark Thornquist | |
| | Matt J Barnett | |
| P2860 | cites work | Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis | Q37686071 |
| | Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies | Q37974152 |
| | International variation in prostate cancer incidence and mortality rates. | Q38935652 |
| | The association of body mass index and prostate-specific antigen in a population-based study | Q44009101 |
| | Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers | Q45187118 |
| | (n-6) PUFA increase and dairy foods decrease prostate cancer risk in heavy smokers. | Q50690524 |
| | Statistical design and monitoring of the carotene and retinol efficacy trial (CARET) | Q57055401 |
| | Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults | Q63258542 |
| | Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis | Q24625223 |
| | Grading of prostatic adenocarcinoma: current state and prognostic implications | Q28066111 |
| | Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 |
| | Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data | Q33688916 |
| | Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults | Q34041755 |
| | Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 |
| | Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study | Q34641998 |
| | Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer | Q34716253 |
| | Beyond body mass index | Q34742832 |
| | Biological mechanisms linking obesity and cancer risk: new perspectives | Q35007716 |
| | Patterns and correlates of physical activity behaviour over 10 years in older adults: prospective analyses from the English Longitudinal Study of Ageing | Q35466690 |
| | Body size and composition and prostate cancer risk: systematic review and meta-regression analysis | Q36577688 |
| | Obesity and cancer risk: the role of the insulin-IGF axis | Q36587115 |
| | Obesity and prostate cancer: a role for adipokines | Q36776401 |
| | Obesity, metabolic syndrome, and prostate cancer | Q37081269 |
| | Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? | Q37280719 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 212-219 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | European Journal of Cancer Prevention | Q5412711 |
| P1476 | title | Body mass index and prostate cancer risk in the Carotene and Retinol Efficacy Trial | |
| P478 | volume | 28 | |